FIELD: chemistry.
SUBSTANCE: invention relates to a method of producing compounds of formula where R1a and R1b are selected from H and F and one of R1a and R1b is F, Het is tetrazolyl, optionally substituted with methyl, R2 is selected from benzyl and C1-C6 alkyl, optionally substituted with a halogen or C1-C4 alkyloxy. The present method includes combining compounds and where X is selected from Cl, Br, I and trifluoromethanesulphonate, Y is selected from BF3 and BR3R4, R3 and R4 are selected from OH, C1-C6monoalcohols and C1-C6diatomic alcohols, or where R3 and R4 together with B, to which they are attached, form a cyclic boronate optionally substituted with methyl.
EFFECT: obtaining oxazolidinones.
22 cl, 10 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
OXAZOLIDINONES AND THE METHOD OF THEIR CLEANING | 2009 |
|
RU2659792C1 |
OXAZOLIDINE-CONTAINING DIMER COMPOUNDS, COMPOSITIONS AND METHODS OF THEIR OBTAINING AND APPLICATION | 2010 |
|
RU2557910C2 |
MACROCYCLIC HEPATITIS TYPE C VIRUS INHIBITORS | 2006 |
|
RU2419619C2 |
AZAPEPTIDE DERIVATIVES | 2008 |
|
RU2448958C2 |
PYRIMIDINE COMPOUNDS CONTAINING ACID GROUPS | 2017 |
|
RU2782066C2 |
BENZIMIDAZOLE DERIVATIVES AS ERBB TYROSINE KINASE INHIBITORS FOR TREATING CANCER | 2015 |
|
RU2741914C2 |
MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS | 2006 |
|
RU2441870C2 |
PYRAZOLOPYRIDINE DERIVATIVES AS NADPH-OXIDASE INHIBITORS | 2009 |
|
RU2538041C2 |
ARYLSULPHONAMIDE CCR3 ANTAGONISTS | 2010 |
|
RU2539591C2 |
VEGF NEUTRALISING PRODRUGS FOR THE TREATMENT OF OCULAR CONDITIONS | 2013 |
|
RU2673881C2 |
Authors
Dates
2015-07-10—Published
2009-10-09—Filed